380 related articles for article (PubMed ID: 26289248)
1. Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Notcutt WG
Neurotherapeutics; 2015 Oct; 12(4):769-77. PubMed ID: 26289248
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system and multiple sclerosis.
Baker D; Pryce G
Curr Pharm Des; 2008; 14(23):2326-36. PubMed ID: 18781983
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L; Bisogno T; Di Marzo V
Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Pryce G; Baker D
Handb Exp Pharmacol; 2015; 231():213-31. PubMed ID: 26408162
[TBL] [Abstract][Full Text] [Related]
6. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
7. [Cannabinoids for symptomatic therapy of multiple sclerosis].
Husseini L; Leussink VI; Warnke C; Hartung HP; Kieseier BC
Nervenarzt; 2012 Jun; 83(6):695-704. PubMed ID: 22080198
[TBL] [Abstract][Full Text] [Related]
8. Towards cannabis and cannabinoid treatment of multiple sclerosis.
Croxford JL; Miller SD
Drugs Today (Barc); 2004 Aug; 40(8):663-76. PubMed ID: 15510238
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid-Based Medicines and Multiple Sclerosis.
Manera C; Bertini S
Adv Exp Med Biol; 2021; 1264():111-129. PubMed ID: 33332007
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids and multiple sclerosis.
Pertwee RG
Pharmacol Ther; 2002 Aug; 95(2):165-74. PubMed ID: 12182963
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.
Khan H; Ghori FK; Ghani U; Javed A; Zahid S
Mol Biol Rep; 2022 Jun; 49(6):5117-5131. PubMed ID: 35182322
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
13. Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Vermersch P
Expert Rev Neurother; 2011 Apr; 11(4 Suppl):15-9. PubMed ID: 21449855
[TBL] [Abstract][Full Text] [Related]
14. Role of cannabinoids in the treatment of pain and (painful) spasticity.
Karst M; Wippermann S; Ahrens J
Drugs; 2010 Dec; 70(18):2409-38. PubMed ID: 21142261
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C
Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512
[TBL] [Abstract][Full Text] [Related]
16. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids in multiple sclerosis: do they have a therapeutic role?
Killestein J; Uitdehaag BM; Polman CH
Drugs; 2004; 64(1):1-11. PubMed ID: 14723555
[TBL] [Abstract][Full Text] [Related]
18. The use of cannabinoids in multiple sclerosis.
Teare L; Zajicek J
Expert Opin Investig Drugs; 2005 Jul; 14(7):859-69. PubMed ID: 16022575
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
Centonze D; Mori F; Koch G; Buttari F; Codecà C; Rossi S; Cencioni MT; Bari M; Fiore S; Bernardi G; Battistini L; Maccarrone M
Neurol Sci; 2009 Dec; 30(6):531-4. PubMed ID: 19768368
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic use of cannabinoids in neurology].
Schwenkreis P; Tegenthoff M
Schmerz; 2003 Oct; 17(5):367-73. PubMed ID: 14513344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
